Table of Contents Author Guidelines Submit a Manuscript
Pathology Research International
Volume 2016, Article ID 2164609, 9 pages
http://dx.doi.org/10.1155/2016/2164609
Research Article

Predictive Response Value of Pre- and Postchemoradiotherapy Variables in Rectal Cancer: An Analysis of Histological Data

1Department of Surgery, Digestive Surgery Service, Hospital de Santo António, Centro Hospitalar do Porto, Largo Abel Salazar, 4099-003 Porto, Portugal
2Department of Community Health, Instituto de Ciências Biomédicas Abel Salazar, Rua Jorge Viterbo Ferreira, No. 228, 4050-313 Porto, Portugal
3Department of Pathology, Pathological Anatomy Service, Hospital de Santo António, Centro Hospitalar do Porto, Largo Professor Abel Salazar, 4099-003 Porto, Portugal
4Department of Pathology and Molecular Immunology, Instituto de Ciências Biomédicas Abel Salazar, Rua Jorge Viterbo Ferreira, No. 228, 4050-313 Porto, Portugal

Received 29 July 2015; Accepted 30 September 2015

Academic Editor: Shahid Pervez

Copyright © 2016 Marisa D. Santos et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Sauer, T. Liersch, S. Merkel et al., “Preoperativeversus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO -94 randomized phase III trial afteramedian follow-up of 11 years,” Journal of Clinical Oncology, vol. 30, no. 16, pp. 1926–1933, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. Y.-C. Lee, C.-C. Hsieh, and J.-P. Chuang, “Prognostic significance of partial tumor regression after preoperative chemoradiotherapy for rectal cancer: a meta-analysis,” Diseases of the Colon & Rectum, vol. 56, no. 9, pp. 1093–1101, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. S. T. Martin, H. M. Heneghan, and D. C. Winter, “Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer,” British Journal of Surgery, vol. 99, no. 7, pp. 918–928, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Rodel, P. Martus, and T. Papadoupolos, “Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer,” Journal of Clinical Oncology, vol. 23, no. 34, pp. 8688–8696, 2005. View at Publisher · View at Google Scholar
  5. P. Roy, S. Serra, E. Kennedy, and R. Chetty, “The prognostic value of grade of regression and oncocytic change in rectal adenocarcinoma treated with neo-adjuvant chemoradiotherapy,” Journal of Surgical Oncology, vol. 105, no. 2, pp. 130–134, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Topova, G. Hellmich, E. Puffer et al., “Prognostic value of tumor response to neoadjuvant therapy in rectal carcinoma,” Diseases of the Colon and Rectum, vol. 54, no. 4, pp. 401–411, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. F. M. Vecchio, V. Valentini, B. D. Minsky et al., “The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer,” International Journal of Radiation Oncology, Biology, Physics, vol. 62, pp. 752–760, 2005. View at Google Scholar
  8. J. M. D. Wheeler, E. Dodds, B. F. Warren et al., “Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade,” Diseases of the Colon & Rectum, vol. 47, no. 12, pp. 2025–2031, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. A.-M. Mandard, F. Dalibard, J.-C. Mandard et al., “Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma: clinicopathologic correlations,” Cancer, vol. 73, no. 11, pp. 2680–2686, 1994. View at Publisher · View at Google Scholar · View at Scopus
  10. M. D. Santos, C. Silva, A. Rocha, E. Matos, C. Nogueira, and C. Lopes, “Prognostic value of Mandard and Dworak tumor regression grading in rectal cancer: study of a single tertiary center,” ISRN Surgery, vol. 2014, Article ID 310542, 8 pages, 2014. View at Publisher · View at Google Scholar
  11. A. C. Bateman, E. Jaynes, and A. R. Bateman, “Rectal cancer staging post neoadjuvant therapy—how should the changes be assessed?” Histopathology, vol. 54, no. 6, pp. 713–721, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Beddy, J. M. P. Hyland, D. C. Winter et al., “A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy,” Annals of Surgical Oncology, vol. 15, no. 12, pp. 3471–3477, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. T. P. MacGregor, T. S. Maughan, and R. A. Sharma, “Pathological grading of regression following neoadjuvant chemoradiation therapy: the clinical need is now,” Journal of Clinical Pathology, vol. 65, no. 10, pp. 867–871, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. M. D. Santos, C. Silva, A. Rocha, E. Matos, C. Nogueira, and C. Lopes, “Tumor regression grades: can they influence rectal cancer therapy decision tree?” International Journal of Surgical Oncology, vol. 2013, Article ID 572149, 8 pages, 2013. View at Publisher · View at Google Scholar
  15. J. Suárez, R. Vera, E. Balén et al., “Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer,” Colorectal Disease, vol. 10, no. 6, pp. 563–568, 2008. View at Publisher · View at Google Scholar
  16. M. Huebner, B. G. Wolff, T. C. Smyrk, J. Aakre, and D. W. Larson, “Partial pathologic response and nodal status as most significant prognostic factors for advanced rectal cancer treated with preoperative chemoradiotherapy,” World Journal of Surgery, vol. 36, no. 3, pp. 675–683, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Farnault, L. Moureau-Zabotto, C. de Chaisemartin et al., “Predictive factors of tumour response after neoadjuvant chemoradiation for locally advanced rectal cancer and correlation of these factors with survival,” Cancer/Radiothérapie, vol. 15, no. 4, pp. 279–286, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Das, J. M. Skibber, M. A. Rodrigues-Bigas et al., “Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer,” Cancer, vol. 109, no. 9, pp. 1750–1755, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. K.-L. Yang, S.-H. Yang, W.-Y. Liang et al., “Carcinoembryonic antigen (CEA) level, CEA ratio, and treatment outcome of rectal cancer patients receiving pre-operative chemoradiation and surgery,” Radiation Oncology, vol. 8, article 43, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Yan, R. Wang, K. Zhu et al., “Predictors of sensitivity to preoperative chemoradiotherapy of rectal adenocarcinoma,” Tumori, vol. 97, no. 6, pp. 717–723, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. S.-G. Yeo, D. Y. Kim, H. J. Chang et al., “Reappraisal of pretreatment carcinoembryonic antigen in patients with rectal cancer receiving preoperative chemoradiotherapy,” Tumori, vol. 99, no. 1, pp. 93–99, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Tural, F. Selcukbiricik, M. A. Özturk et al., “The relation between pathological complete response and clinical outcome in patients with rectal cancer,” Hepatogastroenterology, vol. 60, no. 126, pp. 1365–1370, 2013. View at Google Scholar
  23. H.-Z. Qiu, B. Wu, Y. Xiao, and G.-L. Lin, “Combination of differentiation and T stage can predict unresponsiveness to neoadjuvant therapy for rectal cancer,” Colorectal Disease, vol. 13, no. 12, pp. 1353–1360, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Oberholzer, M. Menig, A. Kreft et al., “Rectal cancer: mucinous carcinoma on magnetic resonance imaging indicates poor response to neoadjuvant chemoradiation,” International Journal of Radiation Oncology, Biology, Physics, vol. 82, no. 2, pp. 842–848, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Tulchinsky, E. Shmueli, A. Figer, J. M. Klausner, and M. Rabau, “An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer,” Annals of Surgical Oncology, vol. 15, no. 10, pp. 2661–2667, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. J. W. Huh, H. R. Kim, and Y. J. Kim, “Clinical prediction of pathological complete response after preoperative chemoradiotherapy for rectal cancer,” Diseases of the Colon and Rectum, vol. 56, no. 6, pp. 698–703, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. D. W. Dietz, F. Dehdashti, P. W. Grigsby et al., “Tumor hypoxia detected by positron emission tomography with 60Cu-ATSM as a predictor of response and survival in patients undergoing neoadjuvant chemoradiotherapy for rectal carcinoma: a pilot study,” Diseases of the Colon & Rectum, vol. 51, no. 11, pp. 1641–1648, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. X. Meng, Z. Huang, R. Wang, and J. Yu, “Prediction of response to preoperative chemoradiotherapy in patients with locally advanced rectal cancer,” BioScience Trends, vol. 8, no. 1, pp. 11–23, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. J. W. Kim, H. C. Kim, J. W. Park et al., “Predictive value of 18FDG PET-CT for tumour response in patients with locally advanced rectal cancer treated by preoperative chemoradiotherapy,” International Journal of Colorectal Disease, vol. 28, no. 9, pp. 1217–1224, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Everaert, A. Hoorens, C. Vanhove et al., “Prediction of response to neoadjuvant radiotherapy in patients with locally advanced rectal cancer by means of sequential 18FDG-PET,” International Journal of Radiation Oncology Biology Physics, vol. 80, no. 1, pp. 91–96, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Ippolito, L. Monguzzi, L. Guerra et al., “Response to neoadjuvant therapy in locally advanced rectal cancer: assessment with diffusion-weighted MR imaging and 18FDG PET/CT,” Abdominal Imaging, vol. 37, no. 6, pp. 1032–1040, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. S. H. Jung, S. H. Heo, J. W. Kim et al., “Predicting response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer: diffusion-weighted 3 tesla MR imaging,” Journal of Magnetic Resonance Imaging, vol. 35, no. 1, pp. 110–116, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Shanmugan, R. Arrangoiz, J. R. Nitzkorski et al., “Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT,” Annals of Surgical Oncology, vol. 19, no. 7, pp. 2178–2185, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. D. J. Kim, J. H. Kim, J. S. Lim et al., “Restaging of rectal cancer with MR imaging after concurrent chemotherapy and radiation therapy,” Radiographics, vol. 30, no. 2, pp. 503–516, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. C. H. Choi, W. D. Kim, S. J. Lee, and W. Y. Park, “Clinical predictive factors of pathologic tumor response after preoperative chemoradiotherapy in rectal cancer,” Radiation Oncology Journal, vol. 30, no. 3, pp. 99–107, 2012. View at Publisher · View at Google Scholar
  36. A. Restivo, L. Zorcolo, I. M. F. Cocco et al., “Elevated CEA levels and low distance of the tumor from the anal verge are predictors of incomplete response to chemoradiation in patients with rectal cancer,” Annals of Surgical Oncology, vol. 20, no. 3, pp. 864–871, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. L. F. de Campos-Lobato, D. P. Geisler, A. da Luz Moreira, L. Stocchi, D. Dietz, and M. F. Kalady, “Neoadjuvant therapy for rectal cancer: the impact of longer interval between chemoradiation and surgery,” Journal of Gastrointestinal Surgery, vol. 15, no. 3, pp. 444–450, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Habr-Gama, R. O. Perez, I. Proscurshim et al., “Interval between surgery and neoadjuvant chemoradiation therapy for distal rectal cancer: does delayed surgery have an impact on outcome?” International Journal of Radiation Oncology, Biology, Physics, vol. 71, no. 4, pp. 1181–1188, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Garcia-Aguilar, D. D. Smith, K. Avila, E. K. Bergsland, P. Chu, and R. M. Krieg, “Optimal timing of surgery after chemoradiation for advanced rectal cancer: preliminary results of a multicenter, nonrandomized phase II prospective trial,” Annals of Surgery, vol. 254, no. 1, pp. 97–102, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. C. G. Willett and B. G. Czito, “Impact of time duration after neoadjuvant therapy to surgery on response and outcome in rectal cancer patients,” Annals of Surgical Oncology, vol. 15, no. 10, pp. 2636–2638, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. Y.-J. Kim, S. C. Park, D. Y. Kim et al., “No correlation between pretreatment serum CEA levels and tumor volume in locally advanced rectal cancer patients,” Clinica Chimica Acta, vol. 413, no. 3-4, pp. 511–515, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. L. Moureau-Zabotto, B. Farnault, C. de Chaisemartin et al., “Predictive factors of tumor response after neoadjuvant chemoradiation for locally advanced rectal cancer,” International Journal of Radiation Oncology Biology Physics, vol. 80, no. 2, pp. 483–491, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. D. Tural, F. Selcukbiricik, M. A. Özturk et al., “The relation between pathological complete response and clinical outcome in patients with rectal cancer,” Hepato-Gastroenterology, vol. 60, no. 126, pp. 1365–1370, 2013. View at Google Scholar · View at Scopus
  44. U. Wallin, D. Rothenberger, A. Lowry, R. Luepker, and A. Mellgren, “CEA—a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer,” Diseases of the Colon & Rectum, vol. 56, no. 7, pp. 859–868, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. S.-G. Yeo, D. Y. Kim, T. H. Kim et al., “Pathologic complete response of primary tumor following preoperative chemoradiotherapy for locally advanced rectal cancer: long-term outcomes and prognostic significance of pathologic nodal status (KROG 09-01),” Annals of Surgery, vol. 252, no. 6, pp. 998–1004, 2010. View at Publisher · View at Google Scholar
  46. S.-G. Yeo, D. Y. Kim, J. W. Park et al., “Stage-to-stage comparison of preoperative and postoperative chemoradiotherapy for T3 mid or distal rectal cancer,” International Journal of Radiation Oncology Biology Physics, vol. 82, no. 2, pp. 856–862, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. A. K. P. Chan, A. Wong, D. Jenken, J. Heine, D. Buie, and D. Johnson, “Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy,” International Journal of Radiation Oncology, Biology, Physics, vol. 61, no. 3, pp. 665–677, 2005. View at Publisher · View at Google Scholar
  48. H. M. Quah, J. F. Chou, M. Gonen et al., “Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation,” Cancer, vol. 113, pp. 57–64, 2008. View at Google Scholar
  49. P. Luna-Pérez, E. Bustos-Cholico, I. Alvarado et al., “Prognostic significance of circumferential margin involvement in rectal adenocarcinoma treated with preoperative chemoradiotherapy and low anterior resection,” Journal of Surgical Oncology, vol. 90, no. 1, pp. 20–25, 2005. View at Publisher · View at Google Scholar